Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CBLL
CBLL logo

CBLL Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Ceribell Inc (CBLL) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
21.130
1 Day change
-0.28%
52 Week Range
24.330
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Ceribell Inc (CBLL) is not a strong buy for a beginner, long-term investor with $50,000-$100,000 available for investment. While the company has shown revenue growth and positive analyst sentiment, the technical indicators suggest the stock is overbought, and there are no significant positive catalysts or trading signals to support an immediate purchase. A hold is recommended for now.

Technical Analysis

The stock is showing bullish momentum with MACD above 0 and expanding positively, and moving averages are aligned bullishly (SMA_5 > SMA_20 > SMA_200). However, RSI at 80.268 indicates the stock is overbought, suggesting a potential pullback. Key resistance levels are at 20.489 and 21.282, with support at 19.206 and 17.922.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
10

Positive Catalysts

  • Revenue growth of 33.72% YoY in Q4 2025, positive analyst sentiment with a Buy rating and a price target of $28, and a solid beat in Q4 financials.

Neutral/Negative Catalysts

  • No significant hedge fund or insider trading activity, no recent news or event-driven catalysts, and RSI indicates overbought conditions. Additionally, the stock has a 60% chance of declining in the short term based on historical patterns.

Financial Performance

In Q4 2025, revenue increased by 33.72% YoY to $24.78M, net income improved by 7.56% YoY to -$13.53M, and EPS increased by 2.86% YoY to -0.36. Gross margin slightly declined by 0.32% YoY to 87.33%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Canaccord maintains a Buy rating with a lowered price target of $28 from $30, citing a solid Q4 performance and conservative guidance with multiple growth drivers ahead.

Wall Street analysts forecast CBLL stock price to rise
4 Analyst Rating
Wall Street analysts forecast CBLL stock price to rise
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 21.190
sliders
Low
29
Averages
29.67
High
30
Current: 21.190
sliders
Low
29
Averages
29.67
High
30
Canaccord
Buy
downgrade
$30 -> $28
AI Analysis
2026-02-25
Reason
Canaccord
Price Target
$30 -> $28
AI Analysis
2026-02-25
downgrade
Buy
Reason
Canaccord lowered the firm's price target on Ceribell to $28 from $30 and keeps a Buy rating on the shares. The firm said they reported a solid beat for Q4 and gave conservative guidance as the company has multiple drivers upcoming.
Canaccord
Buy
maintain
$29 -> $30
2025-12-17
Reason
Canaccord
Price Target
$29 -> $30
2025-12-17
maintain
Buy
Reason
Canaccord raised the firm's price target on Ceribell to $30 from $29 and keeps a Buy rating on the shares. The firm said they continue to be bullish on the Med-Tech sector heading into 2026. They point to strong underlying demand from an aging population, a focus on acute healthcare needs, the healthy pace of M&A, and a market that is receptive to IPOs as the foundation for our belief in our positive outlook in the upcoming year.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CBLL
Unlock Now

People Also Watch